Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Hepatology (Baltimore, Md.)|February 23, 2023
Targeting YAP-mediated HSC death susceptibility and senescence for treatment of liver fibrosisKuo Du, Raquel Maeso-Díaz, Seh Hoon Oh, et al.
Iscience|September 27, 2021
Hepatocyte activity of the cholesterol sensor smoothened regulates cholesterol and bile acid homeostasis in miceGeorge D Dalton, Seh-Hoon Oh, Linda Tang, et al.
The Journal of Clinical Investigation|October 7, 2009
Real-time imaging of de novo arteriovenous malformation in a mouse model of hereditary hemorrhagic telangiectasiaSung Ok Park, Mamta Wankhede, Young Jae Lee, et al.
The American Journal of Pathology|November 1, 2019
Single-Cell RNA Sequencing Identifies Yes-Associated Protein 1-Dependent Hepatic Mesothelial Progenitors in Fibrolamellar CarcinomaMark L Jewell, Jason R Gibson, Cynthia D Guy, et al.
Hepatology (Baltimore, Md.)|January 27, 2022
Zac1 and the Imprinted Gene Network program juvenile NAFLD in response to maternal metabolic syndromeMarine Baptissart, Christine M Bradish, Brie S Jones, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 19, 2022
Hepatocyte Smoothened Activity Controls Susceptibility to Insulin Resistance and Nonalcoholic Fatty Liver DiseaseTianyi Chen, George Dalton, Seh-Hoon Oh, et al.
JCI Insight|May 19, 2026
Hepatocyte hedgehog signaling controls ferroptosis to alleviate aging-related organ dysfunctionJi Hye Jun, Rajesh K Dutta, Soon-Woo Cho, et al.
Hepatology (Baltimore, Md.)|September 10, 2014
Connective tissue growth factor and integrin αvβ6: a new pair of regulators critical for ductular reaction and biliary fibrosis in miceLiya Pi, Paulette M Robinson, Marda Jorgensen, et al.
Journal of Hepatology|May 8, 2021
Dysregulation of the ESRP2-NF2-YAP/TAZ axis promotes hepatobiliary carcinogenesis in non-alcoholic fatty liver diseaseJeongeun Hyun, Muthana Al Abo, Rajesh Kumar Dutta, et al.
Hepatology (Baltimore, Md.)|April 10, 2023
Targeting senescent hepatocytes using the thrombomodulin-PAR1 inhibitor vorapaxar ameliorates NAFLD progressionRaquel Maeso-Díaz, Kuo Du, Christopher Pan, et al.
Pageof 6